The Association Between Complement Component 2/Complement Factor B Polymorphisms and Age-related Macular Degeneration: A HuGE Review and Meta-Analysis
Authors:
- Ammarin ThakkinstianATAmmarin Thakkinstian
- Mark McEvoyMark McEvoy
- Usha ChakravarthyUCUsha Chakravarthy
- Subhabrata ChakrabartiSCSubhabrata Chakrabarti
- Gareth J. McKayGMGareth J. McKay
- Euijung RyuEREuijung Ryu
- Giuliana SilvestriGSGiuliana Silvestri
- Inderjeet KaurIKInderjeet Kaur
- Peter FrancisPFPeter Francis
- Takeshi IwataTITakeshi Iwata
- Masakazu AkahoriMAMasakazu Akahori
- Astrid ArningAAAstrid Arning
- 5 August 2012
- journal article
- research article
- Published by Oxford University Press (OUP) in American Journal of Epidemiology
- Vol. 176 (5) , 361-372
Abstract
The authors performed a systematic review of the association of complement component 2(C2)/complement factor B (CFB) gene polymorphisms with age-related macular degeneration (AMD). In total, data from 19 studies published between 2006 and 2011 were pooled for 4 polymorphisms: rs9332739 and rs547154 in the C2 gene and rs4151667 and rs641153 in the CFB gene. Data extraction and assessments for risk of bias were independently performed by 2 reviewers. Allele frequencies and allele and genotypic effects were pooled. Heterogeneity and publication bias were explored. Pooled minor allele frequencies for all 4 SNPs were between 4.7% and 9.6% for all polymorphisms, except for an Indian population in which the C allele at rs9332739 was the major allele. For the C2 polymorphisms, the minor C allele at rs9332739 and the minor T allele at rs547154 carried estimated relative risks (odds ratios) of 0.55 (95% confidence interval (CI): 0.46, 0.65) and 0.47 (95% CI: 0.39, 0.57), respectively. For the CFB polymorphisms, the minor A alleles at rs4151667 and rs614153 carried estimated risks of 0.54 (95% CI: 0.45, 0.64) and 0.41 (95% CI: 0.34, 0.51), respectively. These allele effects contributed to an absolute lowering of the risk of all AMD in Caucasian populations by 2.0%–6.0%. This meta-analysis provides a robust estimate of the protective association of C2/CFB with AMD.Keywords
Funding Information
- NIH
This publication has 62 references indexed in Scilit:
- CFH, ELOVL4, PLEKHA1 and LOC387715 genes and susceptibility to age-related maculopathy: AREDS and CHS cohorts and meta-analysesHuman Molecular Genetics, 2006
- Complement Factor H Polymorphism, Complement Activators, and Risk of Age-Related Macular DegenerationJAMA, 2006
- Hypothetical LOC387715 is a second major susceptibility gene for age-related macular degeneration, contributing independently of complement factor H to disease riskHuman Molecular Genetics, 2005
- A pooled case-control study of the apolipoprotein E (APOE) gene in age-related maculopathyOphthalmic Genetics, 2002
- The prevalence of age-related maculopathy The visual impairment projectOphthalmology, 2000
- The Apolipoprotein E ε4 Allele Is Unlikely to Be a Major Risk Factor of Age-Related Macular Degeneration in ChineseOphthalmologica, 2000
- Age-related Macular DegenerationArchives of Ophthalmology (1950), 1998
- Is the incidence of registrable age-related macular degeneration increasing?British Journal of Ophthalmology, 1996
- Prevalence of Age-related Maculopathy in AustraliaOphthalmology, 1995
- The Prevalence of Age-related Maculopathy in the Rotterdam StudyOphthalmology, 1995